Evolution of Muscle Function, Breathlessness and Quality of Life Following Intra or Extra-Abdominal Sepsis in ICU Patients (EMBLemAticS)
Sepsis, Septic Shock
About this trial
This is an interventional other trial for Sepsis
Eligibility Criteria
Inclusion Criteria: Patient over 18 years of age, Patient admitted to a critical care unit at Paris Saint-Joseph Hospital, Sepsis or septic shock (defined by the international consensus conference "sepsis-3"), Sepsis/septic shock less than 72 hours old, Patient affiliated to a health insurance scheme, French-speaking patient, Patient or relative who has given free, informed and express consent. Exclusion Criteria: History of documented chronic muscular disease, whatever the cause (neuromuscular damage, abdominal or diaphragmatic hernia, muscular damage of inflammatory origin, myopathies, etc.), Moribund patients, Patient already included in a type 1 interventional research protocol (RIPH1), Patient under guardianship, Patient deprived of liberty, Patient under court protection, Pregnant patient.
Sites / Locations
- Hôpital Paris Saint-JosephRecruiting
Arms of the Study
Arm 1
Experimental
Ultrasound measurement of the diaphragm and intercostals
The specific research procedures correspond to the addition of : Two additional ultrasound examinations, i.e. at discharge from intensive care and 3 months after hospital discharge: non-invasive examination (duration 20 minutes). Ultrasound is a risk-free, painless procedure involving the placement of an ultrasound probe on the body part under investigation, without the need for a radius or puncture. Questionnaires to assess quality of life (SF-36) and functional impact (LCADL) of dyspnea, carried out at discharge from hospital and at 3 months (duration 15 minutes).